These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26234677)

  • 1. RNF126 promotes homologous recombination via regulation of E2F1-mediated BRCA1 expression.
    Wang Y; Deng O; Feng Z; Du Z; Xiong X; Lai J; Yang X; Xu M; Wang H; Taylor D; Yan C; Chen C; Difeo A; Ma Z; Zhang J
    Oncogene; 2016 Mar; 35(11):1363-72. PubMed ID: 26234677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNF126 Quenches RNF168 Function in the DNA Damage Response.
    Zhang L; Wang Z; Shi R; Zhu X; Zhou J; Peng B; Xu X
    Genomics Proteomics Bioinformatics; 2018 Dec; 16(6):428-438. PubMed ID: 30529286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RB localizes to DNA double-strand breaks and promotes DNA end resection and homologous recombination through the recruitment of BRG1.
    Vélez-Cruz R; Manickavinayaham S; Biswas AK; Clary RW; Premkumar T; Cole F; Johnson DG
    Genes Dev; 2016 Nov; 30(22):2500-2512. PubMed ID: 27940962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rewiring E2F1 with classical NHEJ via APLF suppression promotes bladder cancer invasiveness.
    Richter C; Marquardt S; Li F; Spitschak A; Murr N; Edelhäuser BAH; Iliakis G; Pützer BM; Logotheti S
    J Exp Clin Cancer Res; 2019 Jul; 38(1):292. PubMed ID: 31287003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance.
    Anantha RW; Simhadri S; Foo TK; Miao S; Liu J; Shen Z; Ganesan S; Xia B
    Elife; 2017 Apr; 6():. PubMed ID: 28398198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNF8 regulates assembly of RAD51 at DNA double-strand breaks in the absence of BRCA1 and 53BP1.
    Nakada S; Yonamine RM; Matsuo K
    Cancer Res; 2012 Oct; 72(19):4974-83. PubMed ID: 22865450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F1 facilitates DNA break repair by localizing to break sites and enhancing the expression of homologous recombination factors.
    Choi EH; Kim KP
    Exp Mol Med; 2019 Sep; 51(9):1-12. PubMed ID: 31534120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The BRCA1 ubiquitin ligase and homologous recombination repair.
    Ohta T; Sato K; Wu W
    FEBS Lett; 2011 Sep; 585(18):2836-44. PubMed ID: 21570976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CBP and p300 histone acetyltransferases contribute to homologous recombination by transcriptionally activating the BRCA1 and RAD51 genes.
    Ogiwara H; Kohno T
    PLoS One; 2012; 7(12):e52810. PubMed ID: 23285190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polo-like kinase 1 mediates BRCA1 phosphorylation and recruitment at DNA double-strand breaks.
    Chabalier-Taste C; Brichese L; Racca C; Canitrot Y; Calsou P; Larminat F
    Oncotarget; 2016 Jan; 7(3):2269-83. PubMed ID: 26745677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumors overexpressing RNF168 show altered DNA repair and responses to genotoxic treatments, genomic instability and resistance to proteotoxic stress.
    Chroma K; Mistrik M; Moudry P; Gursky J; Liptay M; Strauss R; Skrott Z; Vrtel R; Bartkova J; Kramara J; Bartek J
    Oncogene; 2017 Apr; 36(17):2405-2422. PubMed ID: 27841863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of an Oncogenic BARD1 Splice Variant Impairs Homologous Recombination and Predicts Response to PARP-1 Inhibitor Therapy in Colon Cancer.
    Ozden O; Bishehsari F; Bauer J; Park SH; Jana A; Baik SH; Sporn JC; Staudacher JJ; Yazici C; Krett N; Jung B
    Sci Rep; 2016 May; 6():26273. PubMed ID: 27197561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum and PARP Inhibitor Resistance Due to Overexpression of MicroRNA-622 in BRCA1-Mutant Ovarian Cancer.
    Choi YE; Meghani K; Brault ME; Leclerc L; He YJ; Day TA; Elias KM; Drapkin R; Weinstock DM; Dao F; Shih KK; Matulonis U; Levine DA; Konstantinopoulos PA; Chowdhury D
    Cell Rep; 2016 Jan; 14(3):429-439. PubMed ID: 26774475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHFR-mediated degradation of RNF126 confers sensitivity to PARP inhibitors in triple-negative breast cancer cells.
    Wu W; Zhao J; Xiao J; Wu W; Xie L; Xie X; Yang C; Yin D; Hu K
    Biochem Biophys Res Commun; 2021 Oct; 573():62-68. PubMed ID: 34388456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ID3 promotes homologous recombination via non-transcriptional and transcriptional mechanisms and its loss confers sensitivity to PARP inhibition.
    Bakr A; Hey J; Sigismondo G; Liu CS; Sadik A; Goyal A; Cross A; Iyer RL; Müller P; Trauernicht M; Breuer K; Lutsik P; Opitz CA; Krijgsveld J; Weichenhan D; Plass C; Popanda O; Schmezer P
    Nucleic Acids Res; 2021 Nov; 49(20):11666-11689. PubMed ID: 34718742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel crosstalk between BRCA1 and poly (ADP-ribose) polymerase 1 in breast cancer.
    Li D; Bi FF; Chen NN; Cao JM; Sun WP; Zhou YM; Li CY; Yang Q
    Cell Cycle; 2014; 13(21):3442-9. PubMed ID: 25485588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNF126-Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple-Negative Breast Cancer to Radiotherapy.
    Liu W; Zheng M; Zhang R; Jiang Q; Du G; Wu Y; Yang C; Li F; Li W; Wang L; Wu J; Shi L; Li W; Zhang K; Zhou Z; Liu R; Gao Y; Huang X; Fan S; Zhi X; Jiang D; Chen C
    Adv Sci (Weinh); 2023 Feb; 10(5):e2203884. PubMed ID: 36563124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L ARP7 Is a BRCA1 Ubiquitinase Substrate and Regulates Genome Stability and Tumorigenesis.
    Zhang F; Yan P; Yu H; Le H; Li Z; Chen J; Liang X; Wang S; Wei W; Liu L; Zhang Y; Ji X; Xie A; Chen W; Han Z; Pu WT; Chen S; Chen Y; Sun K; Ge B; Zhang B
    Cell Rep; 2020 Jul; 32(4):107974. PubMed ID: 32726637
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Poh W; Dilley RL; Moliterno AR; Maciejewski JP; Pratz KW; McDevitt MA; Herman JG
    Clin Cancer Res; 2019 Apr; 25(8):2513-2522. PubMed ID: 30692098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells.
    Yang X; Pan Y; Qiu Z; Du Z; Zhang Y; Fa P; Gorityala S; Ma S; Li S; Chen C; Wang H; Xu Y; Yan C; Ruth K; Ma Z; Zhang J
    Clin Cancer Res; 2018 Apr; 24(7):1629-1643. PubMed ID: 29326282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.